Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. Total Assets 2010–2025
Supernus Pharmaceuticals Inc. annual total assets history from 2011 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Supernus Pharmaceuticals Inc. total assets as of December 31, 2025: 1.45B, a 6.18% increase year-over-year.
- Supernus Pharmaceuticals Inc. total assets for 2025 were 1.45B, a 6.18% increase from 2024.
- Supernus Pharmaceuticals Inc. total assets for 2024 were 1.37B, a 7.08% increase from 2023.
- Supernus Pharmaceuticals Inc. total assets for 2023 were 1.28B, a 24.95% decrease from 2022.
- Supernus Pharmaceuticals Inc. total assets for 2022 were 1.70B.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Supernus Pharmaceuticals Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $1,453 |
| 2024 | $1,368 |
| 2023 | $1,278 |
| 2022 | $1,703 |
| 2021 | $1,689 |
| 2020 | $1,504 |
| 2019 | $1,160 |
| 2018 | $978 |
| 2017 | $424 |
| 2016 | $310 |
| 2015 | $189 |
| 2014 | $137 |
| 2013 | $111 |
| 2012 | $94 |
| 2011 | $54 |
Supernus Pharmaceuticals Inc. Total Assets — FAQ
Supernus Pharmaceuticals Inc. (SUPN) total assets over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SUPN's total assets history?
The chart and table above show Supernus Pharmaceuticals Inc.'s total assets by year and by quarter, including the growth rate.